There’s no doubt about it, Moderna’s (MRNA) profile has increased dramatically since the pandemic’s onset. The biotech name has climbed 206% higher this year, as investors have piled in with
There’s no doubt about it, Moderna’s (MRNA) profile has increased dramatically since the pandemic’s onset. The biotech name has climbed 206% higher this year, as investors have piled in with
Rewind to the end of 2019, and in the dead of winter, the sun appeared to be shining on biotech Amarin (AMRN). Vascepa, the company’s high triglycerides treatment and only
Gilead Sciences (GILD) isn’t a one-trick pony. While the news coverage has largely fixated on its potential COVID-19 treatment, remdesivir, the large-cap has an increasingly diverse pipeline. In addition to
Taking the term penny stock to a whole new level, we have Seanergy Maritime (SHIP). Shares are going for $0.12 apiece following another year of massive share price depreciation. The
And just like that, video conferencing stalwart Zoom (ZM) delivered a total knockout. The company released earnings results for fiscal Q1 2021 on Tuesday, and according to BTIG analyst Matthew